FDA Delays Decision on New Alzheimer ' s Drug

FRIDAY, March 8, 2024 -- Instead of approving the new Alzheimer ' s drug donanemab this month, as was expected, the U.S. Food and Drug Administration will now require the experimental medication be scrutinized more closely by an expert panel, the...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news